Eckert & Ziegler: Court Confirms Mandatory Take-Over Bid for IBt

Eckert & Ziegler Strahlen- und Medizintechnik AG / Legal Matter
20.01.2010 

Dissemination of a Corporate News, transmitted by
DGAP - a company of EquityStory AG.
The issuer / publisher is solely responsible for the content of this announcement.

---

Berlin, January 20, 2010 - The Court of Appeal in Brussels has rejected Eckert & Ziegler's (ISIN DE0005659700) appeal against an injunction of Belgian financial regulator CBFA and confirmed the legitimacy of the requested mandatory take-over bid. It also asked Eckert & Ziegler to pay litigation cost in the amount of 20,186 EUR. The court decision is otherwise not expected to have material consequences for the current take-over bid, and will not affect, for example, the price or the valuation of IBt. Eckert & Ziegler had already voluntarily included the requests of the Belgian financial regulator into its offer. Since the verdict denies a material interest for the claim of Creafund, Eckert & Ziegler assumes that the decision will actually conclude all litigation related to the take-over bid.

Eckert & Ziegler AG, Karolin Riehle, Investor Relations, Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, Fax -112, E-Mail: karolin.riehle@ezag.de, www.ezag.com




20.01.2010 Ad hoc announcement, Financial News and Media Release distributed by DGAP. Media archive at www.dgap-medientreff.de and www.dgap.de

---

 
Language:     English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG               Robert-Rössle-Str.10
              13125 Berlin
              Deutschland
Phone:        49 30 941084-138
Fax:          49 30 941084-112
E-mail:       karolin.riehle@ezag.de
Internet:     www.ezag.de
ISIN:         DE0005659700, DE000A0L1L69
WKN:          565970, A0L1L6
Listed: Regulierter Markt in Frankfurt (Prime Standard), Stuttgart; Freiverkehr in Berlin, München, Düsseldorf, Hamburg  
End of News DGAP News-Service  

---